Index Catalog // Scholar@UC

Start Over

Filtering by: Collections Co-Targeting KRASG12D and the HER family is efficacious in colorectal cancer Subject Pharmaceutical Science

Type:: Dataset
Description/Abstract:: LS513 cells were treated with a combination of varying concentrations of MRTX1133 with varying concentrations of either afatinib, sapitinib, or pelitinib for 72 hours. Absorbances were normalized to DMSO control for % viability. The attached files were compiled in data format from n=2 data sets (6 data points total for each combination) and uploaded to SynergyFinder+ with % viability chosen as response.
Creator/Author:: Kilroy, Mary
Submitter:: Mary Kilroy
Date Uploaded:: 03/07/2025
Date Modified:: 03/07/2025
Date Created:: 2024
License:: Attribution 4.0 International

Search Constraints